Belgian Vaccination Strategy against COVID-19: Season 2025-2026
Are you a health authority, healthcare professional, or citizen looking for verified scientific information on COVID-19 vaccination? Would you like to stay informed of the latest developments in this domain? Discover the scientific advisory report from the Superior Health Council on the COVID-19 vaccination strategy for 2025-2026.
This report updates recommendations for vaccines adapted to the Omicron variant. It also provides a detailed overview of the latest comparative data on vaccine efficacy, heterologous vaccination schedules (using different vaccines for the same person), safety, and side effects, with a particular focus this year on pregnant women.
This document replaces the previous version SHC-9833 of 2024.
Downloads
Related advice reports
Vaccination against seasonal influenza: Winter season 2025-2026
Report 9879
The Superior Health Council shares its vaccination strategy against seasonal flu.
Discover key target groups, recommended vaccines, and the ideal time for vaccination.
Discover key target groups, recommended vaccines, and the ideal time for vaccination.
Vaccination against RSV (adults) – revision 2024
Report 9837
Discover the 2024 recommendations from the SHC on VRS vaccination for adults and seniors. A single dose for primary vaccination provides protection for at least 2 years, according to solid scientific data. Click to learn more!
Vaccination against pneumococcal disease (adults)
Report 9674
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on vaccination against pneumococcal disease for adults.
Maternal Immunisation
Report 8754
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations for vaccination during pregnancy.
Share this page